AskTheDate.com
Back to calendar

Arbutus Biopharma Corporation (ABUS) Earnings

ABUS reports earnings on Friday, July 31, 2026

earnings report
July 31, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.02
Actual EPS: $0.87
EPS surprise: 3000.00%
Company overview
Market Cap$863.2M
PriceUSD 4.37
P/E5.31
EPS (TTM)0.82
52-week high5.38
52-week low3.26
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees19